Peter Brams

425 total citations
19 papers, 355 citations indexed

About

Peter Brams is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Peter Brams has authored 19 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 12 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Molecular Biology. Recurrent topics in Peter Brams's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (8 papers). Peter Brams is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (8 papers). Peter Brams collaborates with scholars based in United States, Denmark and Lebanon. Peter Brams's co-authors include Mogens H. Claësson, Ivor Royston, Kandasamy Hariharan, Leonard G. Presta, Robert L. Shields, Paula Boerner, Philip Lipari, Soulaïma Chamat, Wai Lam W. Ling and W. Robert Bishop and has published in prestigious journals such as The Journal of Immunology, Cancer Research and The Journal of Infectious Diseases.

In The Last Decade

Peter Brams

19 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Brams United States	9	163	139	110	79	57	19	355
Katsushi Tokunaga Japan	13	75 0.5×	248 1.8×	28 0.3×	43 0.5×	26 0.5×	16	406
Karine Bernardeau France	14	95 0.6×	246 1.8×	73 0.7×	14 0.2×	96 1.7×	19	457
Alexandra Gonzalez France	7	212 1.3×	53 0.4×	57 0.5×	131 1.7×	110 1.9×	10	389
A Leprini Italy	10	87 0.5×	325 2.3×	63 0.6×	17 0.2×	42 0.7×	31	483
Manuela Stella Italy	7	160 1.0×	59 0.4×	78 0.7×	11 0.1×	140 2.5×	10	356
M Svenson Denmark	9	48 0.3×	236 1.7×	118 1.1×	20 0.3×	48 0.8×	9	398
Bochao Zhang United States	9	97 0.6×	249 1.8×	68 0.6×	9 0.1×	52 0.9×	10	369
Juan Estrada United States	8	110 0.7×	81 0.6×	37 0.3×	11 0.1×	87 1.5×	17	235
Heather C. Workman United States	7	160 1.0×	98 0.7×	49 0.4×	10 0.1×	86 1.5×	8	293
J.A. van Roon Netherlands	8	97 0.6×	160 1.2×	53 0.5×	11 0.1×	75 1.3×	19	420

Countries citing papers authored by Peter Brams

Since Specialization

Citations

This map shows the geographic impact of Peter Brams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Brams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Brams more than expected).

Fields of papers citing papers by Peter Brams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Brams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Brams. The network helps show where Peter Brams may publish in the future.

Co-authorship network of co-authors of Peter Brams

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Brams. A scholar is included among the top collaborators of Peter Brams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Brams. Peter Brams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zhang, Jing, Wenhua Shi, Min Chen, et al.. (2022). Abstract 3590: ZL-1218, a novel anti-CCR8 antibody, exerts potent antitumor effect by depleting intratumoral regulatory T cells. Cancer Research. 82(12_Supplement). 3590–3590. 1 indexed citations

Adler, Adam S., Daniel Bedinger, Matthew S. Adams, et al.. (2018). A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library. mAbs. 10(3). 431–443. 24 indexed citations

Passmore, David, Peter Brams, M. S. Srinivasan, et al.. (2010). Abstract 2587: In vitro plasma stability of human anti-CD70 antibody drug conjugate, MDX-1203. Cancer Research. 70(8_Supplement). 2587–2587. 2 indexed citations

Wang, Yan, Denise Williams, Yaolin Wang, et al.. (2005). Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody. Molecular Cancer Therapeutics. 4(8). 1214–1221. 140 indexed citations

Brams, Peter, Amelia Black, Eduardo A. Padlan, et al.. (2001). A humanized anti-human CD154 monoclonal antibody blocks CD154–CD40 mediated human B cell activation. International Immunopharmacology. 1(2). 277–294. 36 indexed citations

Nakamura, Takehiko, William S. Kloetzer, Peter Brams, et al.. (2000). In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain. International Journal of Immunopharmacology. 22(2). 131–141. 41 indexed citations

Chamat, Soulaïma, Edward E. Walsh, Darrell R. Anderson, et al.. (1999). Human Monoclonal Antibodies Isolated from Spontaneous Epstein‐Barr Virus–Transformed Tumors of Hu‐SPL‐SCID Mice and Specific for Fusion Protein Display Broad Neutralizing Activity Toward Respiratory Syncytial Virus. The Journal of Infectious Diseases. 180(2). 268–277. 7 indexed citations

Brams, Peter, Edward E. Walsh, Soulaïma Chamat, et al.. (1999). Two Neutralizing Human Anti-RSV Antibodies: Cloning, Expression, and Characterization. Molecular Medicine. 5(1). 35–45. 6 indexed citations

Coccia, Marco & Peter Brams. (1998). High Titer, Prostate Specific Antigen-Specific Human IgG Production by hu-PBL-SCID Mice Immunized with Antigen-Mouse IgG2a Complex-Pulsed Autologous Dendritic Cells. The Journal of Immunology. 161(10). 5772–5780. 11 indexed citations

10.

Brams, Peter, et al.. (1998). Antigen-Specific IgG Responses from Naive Human Splenocytes: In Vitro Priming Followed by Antigen Boost in the SCID Mouse. The Journal of Immunology. 160(5). 2051–2058. 13 indexed citations

11.

Royston, Ivor, et al.. (1993). Factors Affecting Production of Antibodies to Prostate Antigens by In Vitro -Primed Human Splenocytes. Hybridoma. 12(4). 381–389. 4 indexed citations

12.

Brams, Peter, Ivor Royston, & Paula Boerner. (1993). In vitro priming of human lymphocytes. II. Induction of antigen-specific IgG responses by repeated antigen stimulation. Human Antibodies. 4(2). 57–65. 6 indexed citations

13.

Brams, Peter, et al.. (1993). In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements. Human Antibodies. 4(2). 47–56. 8 indexed citations

14.

Brams, Peter, Ivor Royston, & Paula Boerner. (1993). In vitro priming of human lymphocytes. I. IL-2 and IL-4 requirements.. PubMed. 4(2). 47–56. 6 indexed citations

15.

Boerner, Paula, et al.. (1991). Production of antigen-specific human monoclonal antibodies from in vitro-primed human splenocytes. The Journal of Immunology. 147(1). 86–95. 13 indexed citations

16.

Claësson, Mogens H., et al.. (1990). T‐Cell Activation. III. Attempts to Activate MHC Class I‐Negative and Class I‐Transfected EL4 T‐Lymphoma Cells by Immobilized Anti‐CD3 Antibody. Scandinavian Journal of Immunology. 32(1). 29–35. 5 indexed citations

17.

Brams, Peter & Mogens H. Claësson. (1989). T-cell activation. I. Evidence for a functional linkage between class I MHC antigens and the Tc-Ti complex.. PubMed. 66(3). 348–53. 23 indexed citations

18.

Brams, Peter, et al.. (1987). Purification and characterization of an inducible mitochondrial DNA polymerase from Tetrahymena thermophila. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 908(2). 150–157. 4 indexed citations

19.

Brams, Peter, David E. Pettijohn, Monica R. Brown, & Lennart Olsson. (1987). In vitro B-lymphocyte antigen priming against both non-immunogenic and immunogenic molecules requiring low amounts of antigen and applicable in hybridoma technology. Journal of Immunological Methods. 98(1). 11–22. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact